TN2013000265A1 - Anti-cd38 antibodies - Google Patents

Anti-cd38 antibodies

Info

Publication number
TN2013000265A1
TN2013000265A1 TNP2013000265A TN2013000265A TN2013000265A1 TN 2013000265 A1 TN2013000265 A1 TN 2013000265A1 TN P2013000265 A TNP2013000265 A TN P2013000265A TN 2013000265 A TN2013000265 A TN 2013000265A TN 2013000265 A1 TN2013000265 A1 TN 2013000265A1
Authority
TN
Tunisia
Prior art keywords
antibodies
disclosed
cynomolgus
bind
therapeutic
Prior art date
Application number
TNP2013000265A
Other languages
French (fr)
Inventor
Kathleen Ann Elias
Gregory Landes
Shweta Singh
Wouter Korver
Andrew Walling Drake
Mary Haak-Frendscho
Gyorgy Pal Snell
Vinay Bhaskar
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/068235 external-priority patent/WO2012092612A1/en
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2013000265A1 publication Critical patent/TN2013000265A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
TNP2013000265A 2011-05-11 2013-06-21 Anti-cd38 antibodies TN2013000265A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161485104P 2011-05-11 2011-05-11
PCT/US2011/068235 WO2012092612A1 (en) 2010-12-30 2011-12-30 Anti-cd38 antibodies

Publications (1)

Publication Number Publication Date
TN2013000265A1 true TN2013000265A1 (en) 2014-11-10

Family

ID=54359573

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000265A TN2013000265A1 (en) 2011-05-11 2013-06-21 Anti-cd38 antibodies

Country Status (1)

Country Link
TN (1) TN2013000265A1 (en)

Similar Documents

Publication Publication Date Title
MX2020012426A (en) Anti-cd38 antibodies.
PH12014502406B1 (en) Anti-il-23p19 antibodies
PH12014501108A1 (en) Anti-il-36r antibodies
MX350200B (en) Human antibodies and antibody-drug conjugates against cd74.
MX362039B (en) Anti-il-23 antibodies.
MY155950A (en) Anti-cd40 antibodies
MX340295B (en) Monoclonal antibodies against c-met.
NZ707086A (en) Anti-cd40 antibodies and methods of use
UA109464C2 (en) Spiro-oxindoles as mdm2 antagonists
SG194701A1 (en) Anti-cd40 antibodies and methods of use
MX349004B (en) New compounds.
AU2014247175A8 (en) Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 and methods of use
SG184310A1 (en) Antibodies that bind human cd27 and uses thereof
MX347734B (en) S100a4 antibodies and therapeutic uses thereof.
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
MX364229B (en) COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES.
MX336682B (en) Antibodies against human csf-1r and uses thereof.
MX2014004074A (en) Methods of treating liver conditions using notch2 antagonists.
TN2013000265A1 (en) Anti-cd38 antibodies
TN2014000207A1 (en) Anti il-36r antibodies
TN2013000186A1 (en) Anti-il-23 antibodies
TN2013000202A1 (en) Spiro-oxindole mdm2 antagonists